Skip to content

Diagnostic and Prognostic Value of Combination Biomarkers in the Critically Ill Patient With Sepsis.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01687010
Enrollment
300
Registered
2012-09-18
Start date
2012-03-31
Completion date
2012-10-31
Last updated
2012-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diagnostic and Predictive Value

Keywords

CRP, PCT, IL-6, Diagnosis, Prediction

Brief summary

Sepsis is a common cause for morbidity and mortality in critically ill patients. With the development of medical skills, the mortality is still remain very high. Inappropriateness of initial antibiotic treatment is an important risk factor for mortality and effective antimicrobial administration within the first hour of documented hypotension was associated with increased survival to hospital discharge in adult patients with septic shock. However, the early treatment based on early diagnosis.But it is very difficult to diagnosis because of lack of specific clinic symptom and sign.When severe sepsis occur, biomarker could be helpful to diagnosis. Unfortunately, the diagnostic value of single biomarker is limited. Therefore, combine several biomarkers could enhance the diagnostic value.

Interventions

None listed

Sponsors

Southeast University, China
CollaboratorOTHER
Jianfeng Xie
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Critically ill patients admitted into ICU

Exclusion criteria

* Age younger than 18 years * Refuse to participate in this study

Countries

China

Contacts

Primary ContactJianfeng Xie, M.D.
seuicu@yahoo.com.cn+8602583272201

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026